Stereoselectivity of binding of alpha-(N-benzylamino)benzylphosphonic acids to prostatic acid phosphatase.
Article Details
- CitationCopy to clipboard
Vovk AI, Mischenko IM, Tanchuk VY, Kachkovskii GA, Sheiko SY, Kolodyazhnyi OI, Kukhar VP
Stereoselectivity of binding of alpha-(N-benzylamino)benzylphosphonic acids to prostatic acid phosphatase.
Bioorg Med Chem Lett. 2008 Aug 15;18(16):4620-3. doi: 10.1016/j.bmcl.2008.07.021. Epub 2008 Jul 10.
- PubMed ID
- 18672366 [ View in PubMed]
- Abstract
The inhibition effects of enantiomerically pure alpha-(N-benzylamino)benzylphosphonic acids and their derivatives on human prostatic acid phosphatase have been investigated. As expected, (R)-alpha-(N-benzylamino)benzylphosphonic acid demonstrated higher affinity for the enzyme than (S)-enantiomer. At the same time, (1R,2S)-phenyl[(1-phenylethyl)amino]methylphosphonic acid was found to be a significantly weaker inhibitor than its (1S,2R)-analogue. The enantioselectivity has been explained using a molecular modeling approach by computational docking of inhibitors into active center of prostatic acid phosphatase.
DrugBank Data that Cites this Article
- Binding Properties
Drug Target Property Measurement pH Temperature (°C) Alpha-Benzyl-Aminobenzyl-Phosphonic Acid Prostatic acid phosphatase IC 50 (nM) 4 N/A N/A Details